Breast cancer-related lymphedema

Mayo Clinic Proceedings

Volumn 80, Issue 11, 2005, Pages 1480-1484

  Morrell, Rosalyn M ^a   Halyard, Michele Y ^a   Schild, Steven E ^a   Ali, Muna S ^a   Gunderson, Leonard L ^a   Pockaj, Barbara A ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; COUMARIN; DIURETIC AGENT; HYALURONIDASE; PANTOTHENIC ACID; PYRONE DERIVATIVE; SELENIUM;

BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER RADIOTHERAPY; COMPRESSION THERAPY; DIARRHEA; DISEASE SEVERITY; HUMAN; INFECTION; KINESIOTHERAPY; LYMPH NODE DISSECTION; LYMPHEDEMA; NAUSEA; REVIEW; SENTINEL LYMPH NODE BIOPSY; TACHYCARDIA; UNITED STATES; VOMITING;

EID: 27644446046     PISSN: 00256196     EISSN: None     Source Type: Journal    
DOI: 10.4065/80.11.1480     Document Type: Review

References (60)

1. American Cancer Society. Estimated new cancer cases for selected cancer sites by state, US, 2005. In: Cancer Facts & Figures 2005. Available at: www.cancer.org/docroot/MED/content/downloads/ MED_1_1x_CFF2005 _Estimated_New_Cases_Sites_by_State.asp. Accessibility verified October 7, 2005.
2. American Cancer Society. Estimated cancer deaths for selected cancer sites by state, US, 2005. In: Cancer Facts & Figures 2005. Available at: www.cancer.org/docroot/MED/content/downloads/ MED_1_1x_CFF2005 _Estimated_Deaths_Sites_by_State.asp. Accessibility verified October 7, 2005.
3. Brennan MJ, DePompolo RW, Garden FH. Focused review: postmastectomy lymphedema. Arch Phys Med Rehabil. 1996;77(suppl 3):S74-S80.
4. Kobayashi MR, Miller TA. Lymphedema. Clin Plast Surg. 1987;14:303-313.
5. Pipinos II, Baxter TB. The lymphatics. In: Townsend CM, Beauchamp RD, Evers BM, Mattox KL, eds. Sabiston Textbook of Surgery. 17th ed. Philadelphia, Pa: WB Saunders Co; 2004:2071-2079.
6. World Health Organization. Lymphatic filariasis. September 2000. Available at: www.who.int/mediacentre/factsheets/fs102/en/.Accessibility verified October 7, 2005.
7. Petropoulos P. Lymphedema. In: Ferri FF, ed. Ferri's Clinical Advisor: Instant Diagnosis and Treatment. St Louis, Mo: Mosby; 2005:490-491.
8. Kern KA. Achieving the lowest false-negative rate in peritumoral breast lymphatic mapping: the oncologic search for the Holy Grail. Ann Surg Oncol. 2003;10:486-487.
9. Nathanson SD, Wachna DL, Gilman D, Karvelis K, Havstad S, Ferrara J. Pathways of lymphatic drainage from the breast. Ann Surg Oncol. 2001;8:837-843.
10. Chang JC, Hilsenbeck SG. Prognostic and predictive markers. In: Harris JR, Lippman ME, Morrow M, Osborne CK, eds. Diseases of the Breast. 3rd ed. Philadelphia, Pa: Lippincott Williams & Wilkins; 2004:675-696.
11. Woodward WA, Strom EA, Tucker SL, et al. Changes in the 2003 American Joint Committee on Cancer staging for breast cancer dramatically affect stage-specific survival. J Clin Oncol. 2003;21:3244-3248.
12. Ries LAG, Eisner MP, Kosary CL, et al, eds. SEER Cancer Statistics Review, 1975-2000. Bethesda, Md: National Cancer Institute; 2003.
13. Pressman PI. Surgical treatment and lymphedema. Cancer. 1998;83(12, suppl Am):2782-2787.
14. Liberman L, Cody HS III, Hill AD, et al. Sentinel lymph node biopsy after percutaneous diagnosis of nonpalpable breast cancer. Radiology. 1999;211:835-844.
15. Kelley MC, Hansen N, McMasters KM. Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Am J Surg. 2004;188:49-61.
16. Querci della Rovere G, Ahmad I, Singh P, Ashley S, Daniels IR, Mortimer P. An audit of the incidence of arm lymphoedema after prophylactic level I/II axillary dissection without division of the pectoralis minor muscle. Ann R Coll Surg Engl. 2003;85:158-161.
17. Engel J, Kerr J, Schlesinger-Raab A, Sauer H, Holzel D. Axilla surgery severely affects quality of life: results of a 5-year prospective study in breast cancer patients [published correction appears in Breast Cancer Res Treat. 2003;80:233]. Breast Cancer Res Treat. 2003;79:47-57.
18. Schrenk P, Rieger R, Shamiyeh A, Wayand W. Morbidity following sentinel lymph node biopsy versus axillary lymph node dissection for patients with breast carcinoma. Cancer. 2000;88:608-614.
19. Kissin MW, Querci della Rovere G, Easton D, Westbury G. Risk of lymphoedema following the treatment of breast cancer. Br J Surg. 1986;73:580-584.
20. Herd-Smith A, Russo A, Muraca MG, Del Turco MR, Cardona G. Prognostic factors for lymphedema after primary treatment of breast carcinoma. Cancer. 2001;92:1783-1787.
21. Erickson VS, Pearson ML, Ganz PA, Adams J, Kahn KL. Arm edema in breast cancer patients. J Natl Cancer Inst. 2001;93:96-111.
22. Gerber L, Lampert M, Wood C, et al. Comparison of pain, motion, and edema after modified radical mastectomy vs. local excision with axillary dissection and radiation. Breast Cancer Res Treat. 1992;21:139-145.
23. Blanchard DK, Donohue JH, Reynolds C, Grant CS. Relapse and morbidity in patients undergoing sentinel lymph node biopsy alone or with axillary dissection for breast cancer. Arch Surg. 2003;138:482-487.
24. Schijven MP, Vingerhoets AJ, Rutten HJ, et al. Comparison of morbidity between axillary lymph node dissection and sentinel node biopsy. Eur J Surg Oncol. 2003;29:341-350.
25. Goffman TE, Laronga C, Wilson L, Elkins D. Lymphedema of the arm and breast in irradiated breast cancer patients: risks in an era of dramatically changing axillary surgery. Breast J. 2004;10:405-411.
26. Swenson KK, Nissen MJ, Ceronsky C, Swenson L, Lee MW, Tuttle TM. Comparison of side effects between sentinel lymph node and axillary lymph node dissection for breast cancer. Ann Surg Oncol. 2002;9:745-753.
27. Burak WE, Hollenbeck ST, Zervos EE, Hock KL, Kemp LC, Young DC. Sentinel lymph node biopsy results in less postoperative morbidity compared with axillary lymph node dissection for breast cancer. Am J Surg. 2002;183:23-27.
28. Haid A, Kuehn T, Konstantiniuk P, et al. Shoulder-arm morbidity following axillary dissection and sentinel node only biopsy for breast cancer. Eur J Surg Oncol. 2002;28:705-710.
29. Giuliano AE, Haigh PI, Brennan MB, et al. Prospective observational study of sentinel lymphadenectomy without further axillary dissection in patients with sentinel node-negative breast cancer [published correction appears in J Clin Oncol. 2000;18:3877]. J Clin Oncol. 2000;18:2553-2559.
30. Armer J, Fu MR, Wainstock JM, Zagar E, Jacobs LK. Lymphedema following breast cancer treatment, including sentinel lymph node biopsy. Lymphology. 2004;37:73-91.
31. Purushotham AD, Upponi S, Klevensath MB, et al: Morbidity after sentinel lymph node biopsy in primary breast cancer: results from a randomized controlled trial. J Clin Oncol. 2005;23:4312-4321.
32. Ozaslan C, Kuru B. Lymphedema after treatment of breast cancer. Am J Surg. 2004;187:69-72.
33. Albrecht MR, Zink K, Busch W, Ruhl U. Dissection or irradiation of the axilla in postmenopausal patients with breast cancer, long-term results and long-term effects in 655 patients [in German]. Strahlenther Onkol. 2002;178:510-516.
34. Coen JJ, Taghian AG, Kachnic LA, Assaad SI, Powell SN. Risk of lymphedema after regional nodal irradiation with breast conservation therapy [published correction appears in Int J Radiat Oncol Biol Phys. 2003;56:604]. Int J Radiat Oncol Biol Phys. 2003;55:1209-1215.
35. Meek AG. Breast radiotherapy and lymphedema. Cancer. 1998;83(12, suppl Am):2788-2797.
36. Petrek JA, Pressman PI, Smith RA. Lymphedema: current issues in research and management. CA Cancer J Clin. 2000;50:292-307.
37. Kocak Z, Overgaard J. Risk factors of arm lymphedema in breast cancer patients. Acta Oncol. 2000;39:389-392.
38. Petrek JA, Senie RT, Peters M, Rosen PP. Lymphedema in a cohort of breast carcinoma survivors 20 years after diagnosis. Cancer. 2001;92:1368-1377.
39. Geller BM, Vacek PM, O'Brien P, Seeker-Walker RH. Factors associated with arm swelling after breast cancer surgery. J Womens Health (Larchmt). 2003;12:921-930.
40. Gerber LH. A review of measures of lymphedema. Cancer. 1998;83(12, suppl Am):2803-2804.
41. Szuba A, Rockson SG. Lymphedema: classification, diagnosis and therapy. Vasc Med. 1998;3:145-156.
42. Szuba A, Shin WS, Strauss HW, Rockson S. The third circulation: radionuclide lymphoscintigraphy in the evaluation of lymphedema. J Nucl Med. 2003;44:43-57.
43. Kramer EL. Lymphoscintigraphy: defining a clinical role. Lymphat Res Biol. 2004;2:32-37.
44. Stanton AW, Mellor RH, Cook GJ, et al. Impairment of lymph drainage in subfascial compartment of forearm in breast cancer-related lymphedema. Lymphat Res Biol. 2003;1:121-132.
45. Bourgeois P, Leduc O, Leduc A. Imaging techniques in the management and prevention of posttherapeutic upper limb edemas. Cancer. 1998;83(12, suppl Am):2805-2813.
46. Tiwari A, Cheng KS, Button M, Myint F, Hamilton G. Differential diagnosis, investigation, and current treatment of lower limb lymphedema. Arch Surg. 2003;138:152-161.
47. Ter SE, Alavi A, Kim CK, Merli G. Lymphoscintigraphy: a reliable test for the diagnosis of lymphedema. Clin Nucl Med. 1993;18:646-654.
48. Petrek JA, Heelan MC. Incidence of breast carcinoma-related lymphedema. Cancer. 1998;83(12, suppl Am):2776-2781.
49. Harris SR, Hugi MR, Olivotto IA, Levine M, Steering Committee for Clinical Practice Guidelines for the Care and Treatment of Breast Cancer. Clinical practice guidelines of the care and treatment of breast cancer, 11: lymphedema. CMAJ. 2001;164:191-199.
50. Cheville AL, McGarvey CL, Petrek JA, Russo SA, Thiadens SR, Taylor ME. The grading of lymphedema in oncology clinical trials. Semin Radiat Oncol. 2003;13:214-225.
51. Lerner R. What's new in lymphedema therapy in America? Int J Angiol. 1998;7:191-196.
52. Cheville AL, McGarvey CL, Petrek JA, Russo SA, Taylor ME, Thiadens SR. Lymphedema management. Semin Radiat Oncol. 2003;13;290-301.
53. Rockson SG, Miller LT, Senie R, et al, American Cancer Society Lymphedema Workshop. Workgroup III: diagnosis and management of lymphedema. Cancer. 1998:83(12, suppl Am):2882-2885.
54. Lerner R. Complete decongestive physiotherapy and the Lerner Lymphedema Services Academy of Lymphatic Studies (the Lerner School). Cancer. 1998;83(12, suppl Am):2861-2863.
55. Casley-Smith JR, Morgan RG, Piller NB. Treatment of lymphedema of the arms and legs with 5,6-benzo-[alpha]-pyrone. N Engl J Med. 1993;329:1158-1163.
56. Loprinzi CL, Kugler JW, Sloan JA, et al. Lack of effect of coumarin in women with lymphedema after treatment for breast cancer. N Engl J Med. 1999;340:346-350.
57. Kligman L, Wong RK, Johnston M, Laetsch NS. The treatment of lymphedema related to breast cancer: a systematic review and evidence summary. Support Care Cancer. June 2004;12:421-431.
58. Bruns F, Micke O, Bremer M. Current status of selenium and other treatments for secondary lymphedema. J Support Oncol. 2003;1:121-130.
59. Micke O, Bruns F, Mucke R, et al. Selenium in the treatment of radiation-associated secondary lymphedema. Int J Radiat Oncol Biol Phys. 2003;56:40-49.
60. Subcommittee on Selenium, Committee on Animal Nutrition, Board on Agriculture, National Research Council. Effects of excess selenium. In: Selenium in Nutrition. Revised ed. Washington, DC: National Academy Press; 1983:107-113.